First, we observed that BATF3 OE increased killing of cultured human HER2+ cancer cells by HER2-targeted CAR T cells across donors and effector:target (E:T) ratios (Fig. 5a and Extended Data Fig. 8a,b). This evidence concerns the gene ERBB2 and cancer.